Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

The latest news and analysis of the pharmaceutical and biotech business landscape. Including staff moves, product launches, acquisitions, mergers, collaborations and licensing agreements.

Showing 15 posts of 2343 posts found.

Roche to acquire Carmot Therapeutics for $2.7bn

December 4, 2023 Business Services Obesity, Roche, acquisition, diabetes

Roche has announced that it has entered into a definitive merger agreement with Carmot Therapeutics, in which it will acquire …
News

Syncona to acquire Freeline Therapeutics for $28.3m

November 24, 2023 Business Services Freeline Therapeutics, Pharmacy, acquisition, syncona

Freeline Therapeutics has announced that it has entered into a definitive agreement with newly established portfolio company Syncona, in which …
News

Merck to acquire Caraway Therapeutics for up to $610m

November 22, 2023 Business Services Caraway Therapeutics, MSD, Merck, Pharmacy, acquisition

Merck (known as MSD outside of the US and Canada) and Caraway Therapeutics have announced that they have entered into …
News
carlos-muza-hpjsku2uysu-unsplash_1

AstraZeneca launches health-tech business, Evinova

November 21, 2023 Business Services AstraZeneca, Pharmacy, health-tech

AstraZeneca has announced that it has launched Evinova, its new health-tech business, which it is hoped will become a leading …
News

Astellas Pharma to acquire Propella Therapeutics for $175m

November 20, 2023 Business Services Astellas Pharma, Oncology, Properlla Therapeutics, acquisition

Astellas Pharma and Propella Therapeutics have announced that Astellas and Propella have entered a merger agreement in which Astellas will …
News

Prange Group and Adragos Pharma to acquire Fresenius Kabi’s manufacturing site

November 16, 2023 Business Services Fresenius Kabi, Pharmacy, Prange Group, acquisition

Prange Group and Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for their acquisition of its …
News
milad-fakurian-58z17lnvs4u-unsplash_2

Autifony announces global license and collaboration agreement with Jazz Pharmaceuticals

November 14, 2023 Business Services Autifony, Neurology, collaboration, jazz pharmaceuticals, neurological disorders

Autifony Therapeutics has announced that it has entered an exclusive global licensing agreement with Jazz Pharmaceuticals for up to $770.5m, …
News

Enhanc3D Genomics appoints Hazel Jones as chief operating officer

November 14, 2023 Business Services Enhanc3D Genomics, Hazel Jones, chief operating officer

Enhanc3D Genomics has announced the appointment of Hazel Jones as chief operating officer. This appointment marks part of the company’s …
Appointment

Anthony Johnson appointed NanoSyrinx’s non-executive director

November 14, 2023 Business Services Anthony Johnson, NanoSyrinx, non-executive director

NanoSyrinx has announced the appointment of Anthony Johnson MD to its board as non-executive director. This appointment marks part of …
Appointment

Halozyme and Acumen Pharmaceuticals enter collaboration for Alzheimer’s treatment

November 7, 2023 Business Services Acumen Pharmaceuticals, Alzheimer's disease, Halozyme, Neurology, collaboration

Halozyme Therapeutics has announced a global collaboration and non-exclusive license with Acumen Pharmaceuticals, providing Acumen with access to Halozyme’s Enhanze …
News

Aldeyra Therapeutics and AbbVie enter agreement for development and commercialisation of reproxalap

November 2, 2023 Business Services AbbVie, Aldeyra Therapeutics, Opthalmology, reproxalap

Aldeyra Therapeutics and AbbVie have announced that they have entered into an exclusive option agreement for the license to develop, …
News
glsun-mall-9xmv81sz5fw-unsplash

Samsung Biologics and Kurma Partners announce collaboration for development and manufacturing of biologics

October 24, 2023 Business Services Kurma Partners, Pharmacy, Samsung BioLogics

Samsung Biologics and Kurma Partners have announced a strategic partnership for the development and manufacturing of biologics for Kurma Partners’ …
News

Roche announces acquisition of Telavant

October 23, 2023 Business Services Gastrointestinal tract, Roche, Telavant

Roche has announced that it has entered into a definitive agreement to acquire Telavant Holdings, a Roivant company, owned by …
News

BMS acquires Mirati Therapeutics for $4.8bn

October 9, 2023 Business Services BMS, Mirati Therapeutics, Oncology, acquisition, bristol myers squibb, oncology

Bristol Myers Squibb (BMS) and Mirati Therapeutics have announced that they have entered into a definitive agreement under which BMS …
News

FUJIFILM Diosynth Biotechnologies appoints Maja Pedersen as chief quality officer

October 6, 2023 Business Services Fujifilm, Fujifilm Diosynth Biotechnologies, Maja Pedersen, Pharmacy, appointment, chief quality officer

CEO and president of FUJIFULM Diosynth Biotechnologies Lars Petersen has appointed Maja Pedersen as chief quality officer, where she will …
Appointment

Latest content

British Medical Journal publishes letter calling on government to reduce rate of antidepressant prescribing

December 5, 2023

Genentech shares positive results from phase 3 trial for breast cancer treatment

December 5, 2023

Dr Stefano Gulià appointed as chief scientific officer of Kling Bio

December 5, 2023

Roche to acquire Carmot Therapeutics for $2.7bn

December 4, 2023

Eli Lilly’s Jaypirca approved in US for leukaemia and lymphoma treatment

December 4, 2023